RYJSX
Price
$144.68
Change
-$0.25 (-0.17%)
Updated
Jul 3 closing price
Net Assets
1.21M
UOPSX
Price
$86.48
Change
+$1.68 (+1.98%)
Updated
Jul 3 closing price
Net Assets
1.17B
Interact to see
Advertisement

RYJSX vs UOPSX

Header iconRYJSX vs UOPSX Comparison
Open Charts RYJSX vs UOPSXBanner chart's image
Rydex Japan 2x Strategy A
Price$144.68
Change-$0.25 (-0.17%)
VolumeN/A
Net Assets1.21M
ProFunds UltraNASDAQ-100 Svc
Price$86.48
Change+$1.68 (+1.98%)
VolumeN/A
Net Assets1.17B
RYJSX vs UOPSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYJSX vs. UOPSX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYJSX is a Hold and UOPSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UOPSX has more cash in the bank: 1.17B vs. RYJSX (1.21M). RYJSX pays higher dividends than UOPSX: RYJSX (3.76) vs UOPSX (0.00). RYJSX was incepted earlier than UOPSX: RYJSX (17 years) vs UOPSX (28 years). UOPSX (2.53) is less costly to investors than RYJSX (1.57). UOPSX is a more actively managed with annual turnover of: 22.00 vs. RYJSX (1.54). RYJSX has a lower initial minimum investment than UOPSX: RYJSX (2500) vs UOPSX (15000). UOPSX annual gain was more profitable for investors over the last year : 10.16 vs. RYJSX (9.29). UOPSX return over 5 years is better than : 89.96 vs. RYJSX (27.31).
RYJSXUOPSXRYJSX / UOPSX
Total Expense Ratio1.542.5361%
Annual Report Gross Expense Ratio1.572.5362%
Fund Existence17 years28 years-
Gain YTD16.7477.601220%
Front Load5%N/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.21M1.17B0%
Annual Yield % from dividends3.760.00106,808%
Returns for 1 year9.2910.1691%
Returns for 3 years54.36149.1236%
Returns for 5 years27.3189.9630%
Returns for 10 years66.55534.4112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOAN5.800.09
+1.58%
Manhattan Bridge Capital
ARCT13.780.16
+1.17%
Arcturus Therapeutics Holdings
VLYPO24.680.17
+0.71%
Valley National Bancorp
TFII93.98-0.15
-0.16%
TFI International
VRTS199.10-1.61
-0.80%
Virtus Investment Partners